While studies have assessed patient perspectives on sodium–glucose cotransporter 2 (SGLT-2) therapies used adjunctively with insulin in T1D,23,24 no study has assessed patient perspectives on adjunctive GLP-1RAs. This evidence concerns the gene INS and type 1 diabetes mellitus.